Literature DB >> 1596898

Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.

J A Biegel1, C D Burk, F G Barr, B S Emanuel.   

Abstract

Primitive neuroectodermal tumors of the central nervous system are the most common malignant brain tumors in children. Cytogenetic analysis of these tumors has demonstrated alterations of chromosome 17, in particular isochromosome 17q, as the most frequent chromosomal abnormality detected. Since the consistent loss of a specific chromosomal region in a given tumor type most likely indicates the presence of a tumor related gene in that region, we undertook a combined molecular and cytogenetic approach to examine alterations of chromosome 17 in primitive neuroectodermal tumors. Seven of 14 tumors analyzed demonstrated loss of alleles for loci on 17p. In three of the seven tumors tested, a loss in copy number was observed for only the most telomeric locus on 17p13.3, D17S34. Limited sequence analysis of the same seven tumors did not reveal mutations in four highly conserved coding regions of the p53 gene. These data suggest a new tumor associated locus on 17p distinct from and distal to TP53, which is involved in the initiation or progression of at least a subset of primitive neuroectodermal tumors.

Entities:  

Mesh:

Year:  1992        PMID: 1596898

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

Review 1.  Brain tumours: classification and genes.

Authors:  V P Collins
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

Review 2.  Medulloblastoma-biology and microenvironment: a review.

Authors:  Tiara Byrd; Robert G Grossman; Nabil Ahmed
Journal:  Pediatr Hematol Oncol       Date:  2012-06-28       Impact factor: 1.969

3.  Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas.

Authors:  S Lescop; A Lellouch-Tubiana; G Vassal; C Besnard-Guerin
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

4.  Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.

Authors:  Venkat R Katkoori; Xu Jia; Chakrapani Chatla; Sanjay Kumar; Selvarangan Ponnazhagan; Tom Callens; Ludwine Messiaen; William E Grizzle; Upender Manne
Journal:  Front Biosci       Date:  2008-01-01

5.  The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.

Authors:  H K Shu; M M Kim; P Chen; F Furman; C M Julin; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 6.  Tumor suppressor genes and medulloblastoma.

Authors:  P H Cogen; J D McDonald
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

Review 7.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

8.  Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.

Authors:  G Sauter; G Deng; H Moch; R Kerschmann; K Matsumura; S De Vries; T George; J Fuentes; P Carroll; M J Mihatsch
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

9.  p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.

Authors:  E Karamitopoulou; E Perentes; I Diamantis
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.

Authors:  H Matsumoto; H Matsuyama; K Fukunaga; S Yoshihiro; T Wada; K Naito
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.